Oppenheimer has initiated coverage of Y-mAbs Therapeutics (NASDAQ:YMAB) off at outperform highlighting the biotech's SADA ...
The Rock's filmography has been tough sledding in recent years and his latest Christmas-themed project seems to be more of ...
Meeting to be held on November 20 hosted by Oppenheimer.Don't Miss out on Research Tools:Discover the latest stocks recommended by top Wall ...
Greece’s Thessaloniki Film Festival ends this evening with a screening of The End, the latest feature project from the ...
The Rock can always put a wildly positive spin on any of his movies, but his latest promotional clip takes the cake: he’s ...
Dwayne Johnson had an epiphany while he was watching Christopher Nolan's Oppenheimer in IMAX that shaped the release of his ...
Pure Storage ( PSTG, Financials) saw its shares rise by single digits in Wednesday trading following Oppenheimer's decision ...
Wrestled turned Hollywood star Dwayne 'The Rock' Johnson is facing flak from cinephiles after claiming that it was the ...
Peter Oppenheimer, Goldman Sachs chief global equity strategist, joins 'Money Movers' to discuss the expected economic ...
Oppenheimer analyst Rick Schafer raised the firm’s price target on Nvidia (NVDA) to $175 from $150 and keeps an Outperform rating on the ...
Despite the downgrade of JPMorgan, Oppenheimer remains bullish on Citi (C), Goldman Sachs (GS), and Jefferies Financial Group (JEF), citing their upside potential in an M&A-driven environment.